IDNAvsIJH
iShares Genomics Immunology and Healthcare ETF against iShares Core S&P Mid-Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | IJH | |
|---|---|---|
| Expense ratio | 0.47% | 0.050% |
| Assets | $219M | $126.5B |
| Net flow, 1 month | +$7M | +$823M |
| Net flow, 1 year | +$36M | +$7.7B |
| Return, YTD | +55.4% | +15.1% |
| Return, 1 year | +80.7% | +20.7% |
| Avg daily volume | 46K | 5.9M |
| Holdings | 63 | 415 |
| Listed | Jun 10, 2019 | May 21, 2000 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS